Multimodal Evaluation of Visual Function in Geographic Atrophy versus Normal Eyes
- PMID: 32669830
- PMCID: PMC7337178
- DOI: 10.2147/OPTH.S246245
Multimodal Evaluation of Visual Function in Geographic Atrophy versus Normal Eyes
Abstract
Purpose: To comprehensively evaluate visual function in eyes with geographic atrophy (GA) as compared to normal eyes.
Patients and methods: Sixty-three eyes from 63 patients ≥50 years old were recruited for this observational study; 31 were identified as normal macular health eyes and 32 with GA. Visual function was tested with best corrected visual acuity (BCVA), low luminance visual acuity (LLVA), low luminance deficit (LLD), reading speed, macular integrity microperimetry, fixation stability, and contrast sensitivity function (CSF). Anatomic function was evaluated with spectral-domain optical coherence tomography (SD-OCT) and fundus autofluorescence (FAF). Quality of life and vision were assessed with the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25).
Results: Visual function and quality of life are reduced in patients with GA. Moderate and strong correlations in the GA group were found between maximum reading speed (r = 0.787) (p˂0.01), CS spatial frequency 3 cpd (r = 0.441) (p˂0.05), CS spatial frequency 6 cpd (r = 0.524) (p˂0.01), fixation P1 (r = 0.379) (p˂0.05), macular sensitivity (r = 0.484) (p˂0.05) and atrophic area (r = -0.689) (p˂0.01), and the VFQ-25 composite score.
Conclusion: The decreased visual function is reflected in a poor quality of life in patients with GA. Reading speed, contrast sensitivity, fixation, and macular sensitivity are strongly associated with vision-related quality of life. The results suggest the importance of the reading letter size in patients with GA. Microperimetry and reading speed are useful tools to better assess visual impairment in patients with GA.
Keywords: age-related macular degeneration; geographic atrophy; quality of life; reading speed; visual function.
© 2020 Burguera-Giménez et al.
Conflict of interest statement
No relevant financial or commercial relationship exists for any author.
Figures



Similar articles
-
Phase 1 Clinical Trial of Elamipretide in Intermediate Age-Related Macular Degeneration and High-Risk Drusen: ReCLAIM High-Risk Drusen Study.Ophthalmol Sci. 2021 Dec 22;2(1):100095. doi: 10.1016/j.xops.2021.100095. eCollection 2022 Mar. Ophthalmol Sci. 2021. PMID: 36246187 Free PMC article.
-
Phase 1 Clinical Trial of Elamipretide in Dry Age-Related Macular Degeneration and Noncentral Geographic Atrophy: ReCLAIM NCGA Study.Ophthalmol Sci. 2021 Nov 27;2(1):100086. doi: 10.1016/j.xops.2021.100086. eCollection 2022 Mar. Ophthalmol Sci. 2021. PMID: 36246181 Free PMC article.
-
Müller cells and choriocapillaris in the pathogenesis of geographic atrophy secondary to age-related macular degeneration.Graefes Arch Clin Exp Ophthalmol. 2019 Jun;257(6):1159-1167. doi: 10.1007/s00417-019-04289-z. Epub 2019 Mar 23. Graefes Arch Clin Exp Ophthalmol. 2019. PMID: 30903311
-
The Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration.Ophthalmology. 2018 Mar;125(3):369-390. doi: 10.1016/j.ophtha.2017.08.038. Epub 2017 Oct 27. Ophthalmology. 2018. PMID: 29110945 Review.
-
Introduction to microperimetry and its use in analysis of geographic atrophy in age-related macular degeneration.Curr Opin Ophthalmol. 2015 May;26(3):149-56. doi: 10.1097/ICU.0000000000000153. Curr Opin Ophthalmol. 2015. PMID: 25784112 Review.
Cited by
-
Seeing Beyond Anatomy: Quality of Life with Geographic Atrophy.Ophthalmol Ther. 2021 Sep;10(3):367-382. doi: 10.1007/s40123-021-00352-3. Epub 2021 Jun 5. Ophthalmol Ther. 2021. PMID: 34089491 Free PMC article.
-
Prediction Error Stabilization and Long-Term Standard Results with a Monofocal Intraocular Lens.Vision (Basel). 2022 Jan 13;6(1):5. doi: 10.3390/vision6010005. Vision (Basel). 2022. PMID: 35076638 Free PMC article.
-
Vision-related quality of life is selectively affected by comorbidities in patients with geographic atrophy.BMC Ophthalmol. 2023 Apr 12;23(1):153. doi: 10.1186/s12886-023-02901-9. BMC Ophthalmol. 2023. PMID: 37041490 Free PMC article.
-
Age-related macular degeneration: natural history revisited in geographic atrophy.Eye (Lond). 2025 Feb;39(2):217-227. doi: 10.1038/s41433-024-03443-0. Epub 2024 Oct 29. Eye (Lond). 2025. PMID: 39472501 Review.
-
Clinical Trial Simulation in Geographic Atrophy: Patient, Caregiver, and Trial Site Staff Perspectives.Ophthalmol Ther. 2025 Aug;14(8):1855-1868. doi: 10.1007/s40123-025-01188-x. Epub 2025 Jun 23. Ophthalmol Ther. 2025. PMID: 40549132 Free PMC article.
References
-
- Nowak JZ. Amd-the retinal disease with an unprecised etiopathogenesis: in search of effective therapeutics. Acta Pol Pharm. 2014;71(6):900–916. - PubMed
LinkOut - more resources
Full Text Sources